|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.94 EUR | -2.17% |
|
+1.27% | -6.22% |
| 10:04am | Roche oral drug shown to keep breast cancer at bay, boosting shares | RE |
| 11-17 | Sanofi to Invest EUR300 Million in France to Accelerate AI Strategy |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 13.38x | 1.4x | 0.29x | 2.8x | 9.12x | 10.14x | 4.62% | 127B | ||
| 44.97x | 33.71x | 0.48x | 14.82x | 33.04x | 35.52x | 0.58% | 915B | ||
| 18.05x | 6.12x | 0.2x | 5.35x | 14.8x | 16.25x | 2.59% | 481B | ||
| 56.55x | -551.63x | 0.77x | 7.71x | 18.26x | 18.78x | 2.79% | 414B | ||
| 17.06x | 5.93x | 0.27x | 4.21x | 10.52x | 11.88x | 3.44% | 310B | ||
| 26.84x | 6.08x | 0.56x | 5.1x | 15.1x | 15.9x | 1.8% | 278B | ||
| 18.42x | 5.93x | 0.84x | 4.96x | 11.61x | 12.59x | 3.06% | 255B | ||
| 11.93x | 4.27x | 0.77x | 3.94x | 8.5x | 9.52x | 3.48% | 230B | ||
| 13.49x | 7.39x | 5.49x | 4.83x | 10.02x | 11.48x | 3.7% | 216B | ||
| 25.72x | 19.62x | 0.34x | 6.3x | 10.85x | 14.48x | 2.8% | 184B | ||
| 17.9x | 6.77x | 0.01x | 5.71x | 10.43x | 12.55x | 2.67% | 154B | ||
| 12.73x | 1.57x | 0.32x | 2.93x | 7.36x | 8.51x | 6.79% | 143B | ||
| 27.95x | 5.78x | -0.03x | 8.44x | 18.22x | 18.93x | -.--% | 110B | ||
| 11.13x | 4.82x | -0.06x | 2.69x | 7.8x | 8.15x | 5.28% | 95.29B | ||
| 12.76x | 5.04x | 0.1x | 2.67x | 7.88x | 9.01x | 3.61% | 95.24B | ||
| 32.69x | 7.08x | 3.11x | 10.59x | 20.95x | 22.19x | 2.98% | 90.2B | ||
| 204.68x | 72.76x | -1.01x | 15.91x | 104.48x | 98.78x | -.--% | 60.84B | ||
| 46.58x | 6.93x | 1.43x | 11.24x | 36.92x | 38.83x | 0.45% | 57.72B | ||
| 34.08x | 1.01x | 0.39x | 2.42x | 9.1x | 24.56x | 4.57% | 44.51B | ||
| Average | 34.05x | -18.39x | 0.75x | 6.45x | 19.21x | 20.95x | 2.91% | 224.17B | |
| Weighted average by Cap. | 31.05x | -40.99x | 0.74x | 7.56x | 18.67x | 20.24x | 2.51% |
- Stock Market
- Equities
- SAN Stock
- Sector Sanofi
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















